Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2021-03-10 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
110年2月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, with data presented in a tabular format. It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document length is short (764 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory disclosure of financial data rather than a full financial report or earnings release. There is no indication of it being an announcement of a report publication or a certification. Given the nature of the content and the short length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2021-03-10 Chinese
110年02月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares such as trust shares and pledged shares. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings disclosures. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2021-03-04 Chinese
110年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and senior management. It lists individual holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, management changes, or meeting materials. There is no indication of a report publication, earnings release, or regulatory certification. The document is a typical insider shareholding disclosure, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is short (2551 characters), but it contains substantive data on insider holdings rather than just an announcement or certification. Therefore, the best classification is DIRS with high confidence.
2021-03-04 Chinese
110年1月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company, with percentage changes compared to the previous year. It includes notes explaining the accounting standards and reporting practices but does not contain detailed financial statements or comprehensive analysis. The document length is short (766 characters), and it appears to be a summary or factsheet rather than a full financial report. Therefore, it fits best into the Fund Information / Factsheet (FS) category, which covers brief summaries of key company financials and market info.
2021-02-09 Chinese
110年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (科妍) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it announce or attach a full report. The content is regulatory in nature, providing compliance information about financial guarantees and loans, but it is very short (601 characters) and does not constitute a full financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-02-09 Chinese
110年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of this being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2021-02-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.